US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It is hoped the tool will help to monitor and treat human immunodeficiency-1 infected individuals, as well as inform epidemiologic and genetic surveillance studies who are tracking the ongoing evolution of the virus.
Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1
